Rhode Island General Laws Title 27. Insurance § 27-18-33.3. Patient choice in dispensing of clinician-administered drugs

(1) “ Clinician-administered drug” means an outpatient infused prescription drug other than a vaccine that:

(1) The dispensing and administering and any associated authorizations and approvals are consistent with the provider contract and the issuer's medical and payment policies provided such policies do not prohibit the procurement, administration, and dispensing by an in-network hospital or clinic; and

(2) The reimbursement to the provider shall be negotiated between the health insurer and provider at a rate equal to payments between the insurer and a preferred pharmacy.

(1) In conducting the analysis, the office of the health insurance commissioner may:

(2) The office of the health insurance commissioner shall publish on its website a summary of its analysis, without identifying any health insurers or providers.

(3) The office of the health insurance commissioner may include in its analysis legislative recommendations to improve the reimbursement process for clinician-administered drugs under this section, as necessary. Any recommendations shall include a description of the recommendation's potential costs to consumers, health insurers, providers, and the state.

(4) The office of the health insurance commissioner shall provide the general assembly with their analysis no later than February 28, 2026.